Related Experiment Video
Updated: Mar 14, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
KLF4 Knockdown Attenuates TBI-Induced Neuronal Damage through p53 and JAK-STAT3 Signaling
Da-Ming Cui1, Tao Zeng1, Jie Ren1
1Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Aims:
Traumatic brain injury (TBI) is induced by complex primary and secondary mechanisms that give rise to cell death, inflammation, and neurological dysfunction. Understanding the mechanisms that drive neurological damage as well as those that promote repair can guide the development of therapeutic drugs for TBI. Kruppel-like factor 4 (KLF4) has been reported to negatively regulate axon regeneration of injured retinal ganglion cells (RGCs) through inhibition of JAK-STAT3 signaling. However, the role of KLF4 in TBI remains unreported. Reactive oxygen species (ROS)-induced neuronal death is a pathophysiological hallmark of TBI.
Methods:
In this study, we used H2 O2 -treated RGCs in vitro and the optic nerve crush model in vivo to simulate neuronal damage in TBI. The function of KLF4 in RGC survival and axon regeneration in these models was investigated. In addition, the effects of KLF4 knockdown on neuronal damage after a brain impact that mimics moderate TBI were studied.
Results:
The results show that H2 O2 induces p53-dependent apoptosis of RGCs in vitro through upregulation of KLF4. Additionally, KLF4 knockdown in vivo significantly enhances CNTF-induced axon regeneration of RGCs after optic nerve crush, and more importantly, prevents neuronal damage after a moderate brain impact in rats. Our Western blot analysis and immunoprecipitation assay results indicate that these effects of KLF4 knockdown are mediated by the p53 and JAK-STAT3 pathways.
Conclusion:
These findings provide evidence that KLF4 plays an important role in the pathophysiology of TBI. Blocking KLF4 may be a potential therapeutic strategy for the treatment of TBI, either alone or in combination with agents that target complementary mechanisms.
Insights
Blocking Kruppel-like factor 4 (KLF4) may treat traumatic brain injury (TBI). KLF4 knockdown in rats reduced neuronal damage and improved axon regeneration, suggesting KLF4 is a therapeutic target for TBI.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Traumatic brain injury (TBI) involves complex mechanisms leading to neuronal death and dysfunction.
- Reactive oxygen species (ROS) contribute significantly to TBI-induced neuronal apoptosis.
- Kruppel-like factor 4 (KLF4) is known to inhibit axon regeneration in other contexts but its role in TBI is unexplored.
Purpose of the Study:
- To investigate the role of KLF4 in neuronal damage and repair following TBI.
- To determine if KLF4 inhibition can mitigate TBI-induced pathology.
- To elucidate the molecular pathways (p53, JAK-STAT3) involved in KLF4's function in TBI.
Main Methods:
- Utilized hydrogen peroxide (H2O2)-treated retinal ganglion cells (RGCs) in vitro to model oxidative stress.
- Employed an optic nerve crush model in vivo to assess RGC axon regeneration.
- Investigated the impact of KLF4 knockdown on neuronal survival and damage in a rat model of moderate TBI.
Main Results:
- H2O2 induced p53-dependent apoptosis in RGCs via KLF4 upregulation.
- KLF4 knockdown enhanced nerve growth factor (CNTF)-induced axon regeneration post-optic nerve crush.
- KLF4 knockdown significantly reduced neuronal damage following experimental TBI in rats, mediated by p53 and JAK-STAT3 pathways.
Conclusions:
- KLF4 plays a critical role in the pathological processes of TBI.
- Targeting KLF4 presents a promising therapeutic strategy for TBI treatment.
- Combined therapies involving KLF4 blockade may offer enhanced efficacy for TBI recovery.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway

